Nigeria vs Papua New Guinea: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Nigeria
2.7%
in 2024
Papua New Guinea
2.5%
in 2024
Nigeria rank
9th
Papua New Guinea rank
11th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Nigeria
- Papua New Guinea
How they compare
Nigeria currently reports 2.7% against 2.5% in Papua New Guinea, a difference of 0.2%.
That makes Nigeria's figure about 1.1 times Papua New Guinea's.
Across all 10 years both countries report, Nigeria has been ahead every year.
Nigeria ranks 9th and Papua New Guinea ranks 11th of 246 countries.
Nigeria has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Nigeria | Papua New Guinea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 3.7% | 2.0% | 1.8% | Nigeria |
| 2020s | 3.1% | 2.4% | 0.7% | Nigeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Nigeria or Papua New Guinea?
- Nigeria, at 2.7% against 2.5% in Papua New Guinea as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Nigeria and Papua New Guinea?
- 0.2%, with Nigeria ahead.
- How many years of comparable data are there for Nigeria and Papua New Guinea?
- 10 years are reported by both, from 2015 to 2024.
- How do Nigeria and Papua New Guinea rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Nigeria ranks 9th and Papua New Guinea ranks 11th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.